Table 4.
LOGISTIC REGRESSION RESULTS | |||||||
---|---|---|---|---|---|---|---|
Symptom | Covariates | Unadjusted Model | Adjusted Model | ||||
OR | CI | p-value | OR | CI | p-value | ||
Logistic Regression Results for Total Sample | |||||||
Hot flashes PRE = 58.3% POST = 45.3% |
Overall Model X2=59.53; p<.001 |
||||||
Menopausal status* | 0.56 | 0.35, 0.89 | .015 | 5681.12 | 136.43, 236576.94 | <.001 | |
Age (in 5 year increments) | 1.38 | 1.00, 1.92 | .050 | ||||
Lives alone | 0.92 | 0.51, 1.65 | .770 | ||||
Working for pay | 0.65 | 0.39, 1.07 | .089 | ||||
SCQ score | 1.07 | 0.97, 1.17 | .188 | ||||
Prior HRT | 2.19 | 1.1 0, 4.36 | .026 | ||||
Adjuvant chemotherapy during 12 months | 1.11 | 0.66, 1.87 | .692 | ||||
Radiation therapy during 12 months | 1.11 | 0.59, 2.1 0 | .739 | ||||
Reconstruction during 12 months | 1.52 | 0.63, 3.68 | .352 | ||||
Type of surgery: conservation (ref) vs mastectomy | 0.96 | 0.44, 2.1 0 | .921 | ||||
Age × menopausal status | 0.42 | 0.29, 0.61 | .000 | ||||
Adjusted Regression of Hot Flashes Occurrence on Age, Stratified by Menopausal Status | |||||||
Premenopausal | 1.43 | 0.99, 2.06 | .055 | ||||
Postmenopausal | 0.56 | 0.46, 0.69 | <.001 | ||||
Night Sweats PRE = 44.3% POST = 32.5% |
Overall Model X2=41.70; p<.001 |
||||||
Menopausal status* | 0.59 | 0.37, 0.94 | .026 | 1132.50 | 29.38, 43655.1 | <.001 | |
Age (in 5 year increments) | 1.3 0 | 0.94, 1.8 0 | .117 | ||||
Lives alone | 1.05 | 0.57, 1.92 | .872 | ||||
Working for pay | 0.97 | 0.59, 1.59 | .892 | ||||
SCQ score | 1.04 | 0.95, 1.15 | .397 | ||||
Prior HRT | 2.35 | 1.18, 4.67 | .015 | ||||
Adjuvant chemotherapy during 12 months | 1.04 | 0.62, 1.75 | .872 | ||||
Radiation therapy during 12 months | 0.85 | 0.45, 1.62 | .632 | ||||
Reconstruction during 12 months | 0.91 | 0.38, 2.2 0 | .837 | ||||
Type of surgery: conservation (ref) vs mastectomy | 1.28 | 0.58, 2.82 | .536 | ||||
Age × menopausal status | 0.49 | 0.34, 0.71 | <.001 | ||||
Adjusted Regression of Night Sweats Occurrence on Age, Stratified by Menopausal Status | |||||||
Premenopausal | 1.31 | 0.92, 1.88 | .140 | ||||
Postmenopausal | 0.63 | 0.52, 0.76 | <.001 | ||||
Depression PRE = 34.5% POST = 24.5% |
Overall Model X2 =30.92; p=.001 |
||||||
Menopausal status* | 0.60 | 0.37, 0.99 | .047 | 338.93 | 6.92, 16611.16 | .003 | |
Age (in 5 year increments) | 1.41 | 0.98, 2.02 | .061 | ||||
Lives alone | 0.89 | 0.47, 1.71 | .733 | ||||
Working for pay | 1.02 | 0.60, 1.73 | .937 | ||||
SCQ score | 1.18 | 1.07, 1.30 | .001 | ||||
Prior HRT | 0.83 | 0.39, 1.76 | .620 | ||||
Adjuvant chemotherapy during 12 months | 1.04 | 0.60, 1.79 | .889 | ||||
Radiation therapy during 12 months | 0.82 | 0.42, 1.61 | .571 | ||||
Reconstruction during 12 months | 1.19 | 0.47, 2.98 | .717 | ||||
Type of surgery: conservation (ref) vs mastectomy | 1.16 | 0.51, 2.64 | .725 | ||||
Age × menopausal status | 0.54 | 0.36, 0.8 0 | .002 | ||||
Adjusted Regression of Depression Occurrence on Age, Stratified by Menopausal Status | |||||||
Premenopausal | 1.50 | 1.00, 2.25 | .048 | ||||
Postmenopausal | 0.77 | 0.64, 0.92 | .003 | ||||
Daytime sweats PRE = 39.7% POST = 26.9% |
Overall Model X2=34.535; p=.011 |
||||||
Menopausal status* | 0.53 | 0.33, 0.87 | .011 | 137.20 | 3.53, 5329.31 | .008 | |
Age (in 5 year increments) | 1.3 0 | 0.93, 1.83 | .121 | ||||
Lives alone | 0.78 | 0.42, 1.47 | .446 | ||||
Working for pay | 0.91 | 0.54, 1.51 | .705 | ||||
SCQ score | 1.08 | 0.98, 1.19 | .122 | ||||
Prior HRT | 2.92 | 1.46, 5.83 | .002 | ||||
Adjuvant chemotherapy during 12 months | 0.98 | 0.57, 1.66 | .931 | ||||
Radiation therapy during 12 months | 1.21 | 0.61, 2.39 | .581 | ||||
Reconstruction during 12 months | 0.62 | 0.24, 1.56 | .308 | ||||
Type of surgery: conservation (ref) vs mastectomy | 2.18 | 0.97, 4.93 | .060 | ||||
Age × menopausal status | 0.57 | 0.39, 0.83 | .004 | ||||
Adjusted Regression of Daytime Sweats Occurrence on Age, Stratified by Menopausal Status | |||||||
Premenopausal | 1.27 | 0.89, 1.81 | .190 | ||||
Postmenopausal | 0.74 | 0.63, 0.89 | .001 | ||||
Joint pain or stiffness PRE = 40.0% POST = 51.9% |
Overall Model X2=23.66; p=.014 |
||||||
Menopausal status* | 1.62 | 1.02, 2.57 | .043 | 387.32 | 6.64, 22601.80 | .004 | |
Age (in 5 year increments) | 1.88 | 1.26, 2.79 | .002 | ||||
Lives alone | 0.97 | 0.56, 1.68 | .906 | ||||
Working for pay | 0.89 | 0.55, 1.42 | .614 | ||||
SCQ score | 1.07 | 0.98, 1.17 | .133 | ||||
Prior HRT | 1.00 | 0.54, 1.86 | .993 | ||||
Adjuvant chemotherapy during 12 months | 1.40 | 0.85, 2.32 | .188 | ||||
Radiation therapy during 12 months | 0.63 | 0.34, 1.17 | .145 | ||||
Reconstruction during 12 months | 1.31 | 0.54, 3.16 | .551 | ||||
Type of surgery: conservation (ref) vs mastectomy | 0.61 | 0.28, 1.31 | .206 | ||||
Age × menopausal status | 0.54 | 0.36, 0.83 | .004 | ||||
Adjusted Regression of Joint Pain Occurrence on Age, Stratified by Menopausal Status | |||||||
Premenopausal | 2.07 | 1.33, 3.23 | .001 | ||||
Postmenopausal | 1.00 | 0.86, 1.15 | .947 | ||||
Wake during the night PRE = 61.7% POST = 63.7% |
Overall Model X2=23.12; p=.017 |
||||||
Menopausal status* | 1.08 | 0.67, 1.73 | .764 | 149.89 | 4.59, 4893.95 | .005 | |
Age (in 5 year increments) | 1.25 | 0.91, 1.72 | .170 | ||||
Lives alone | 0.92 | 0.52, 1.63 | .779 | ||||
Working for pay | 0.64 | 0.39, 1.05 | .079 | ||||
SCQ score | 1.10 | 1.00, 1.21 | .058 | ||||
Prior HRT | 1.29 | 0.67, 2.48 | .447 | ||||
Adjuvant chemotherapy during 12 months | 0.90 | 0.53, 1.51 | .678 | ||||
Radiation therapy during 12 months | 1.06 | 0.57, 1.97 | .855 | ||||
Reconstruction during 12 months | 2.53 | 0.99, 6.47 | .052 | ||||
Type of surgery: conservation (ref) vs mastectomy | 0.7 0 | 0.32, 1.54 | .380 | ||||
Age × menopausal status | 0.62 | 0.44, 0.88 | .008 | ||||
Adjusted Regression of Wake During the Night Occurrence on Age, Stratified by Menopausal Status | |||||||
Premenopausal | 1.29 | 0.92, 1.80 | .142 | ||||
Postmenopausal | 0.76 | 0.64, 0.90 | .001 | ||||
Numbness or tingling PRE = 27.8% POST = 29.7% |
Overall Model X2=29.37; p=.002 |
||||||
Menopausal status* | 1.12 | 0.67, 1.86 | .673 | 174.64 | 3.33, 9171.79 | .011 | |
Age (in 5 year increments) | 1.29 | 0.89, 1.87 | .185 | ||||
Lives alone | 1.52 | 0.83, 2.79 | .174 | ||||
Working for pay | 0.74 | 0.44, 1.24 | .253 | ||||
SCQ score | 1.08 | 0.98, 1.18 | .143 | ||||
Prior HRT | 1.05 | 0.52, 2.12 | .900 | ||||
Adjuvant chemotherapy during 12 months | 2.47 | 1.45, 4.20 | .001 | ||||
Radiation therapy during 12 months | 0.82 | 0.42, 1.6 0 | .562 | ||||
Reconstruction during 12 months | 1.06 | 0.42, 2.67 | .905 | ||||
Type of surgery: conservation (ref) vs mastectomy | 1.16 | 0.52, 2.6 0 | .710 | ||||
Age × menopausal status | 0.62 | 0.41, 0.92 | .019 | ||||
Adjusted Regression of Numbness or Tingling Occurrence on Age, Stratified by Menopausal Status | |||||||
Premenopausal | 1.32 | 0.88, 1.98 | .176 | ||||
Postmenopausal | 0.79 | 0.66, 0.93 | .006 |
Abbreviations: CI = confidence interval; HRT = hormone replacement therapy; OR = odds ratio; PRE = premenopausal; POST = postmenopausal; ref = reference group; SCQ = Self-administered Comorbidity Questionnaire; vs = versus
reference group = premenopausal women